Common Contracts
2 similar Common Stock Purchase Warrant contracts by Universal Biosensors Inc
UNIVERSAL BIOSENSORS, INC. COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • December 20th, 2013 • Universal Biosensors Inc • Surgical & medical instruments & apparatus • New York
THIS IS TO CERTIFY that ATHYRIUM OPPORTUNITIES FUND (B) LP, a Delaware limited partnership, and its permitted transferees, successors and permitted assigns (the “Holder”), for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, is entitled to purchase from UNIVERSAL BIOSENSORS, INC., a Delaware corporation (the “Company”), at the price of AUD$1.00 per share (the “Exercise Price”), at any time after the date hereof (the “Commencement Date”) and expiring on December 19, 2020 (the “Expiration Date”), 1,602,319 shares of the fully paid and non-assessable Common Stock (as defined herein), trading in the form of CHESS depositary interests (“CDIs”) on the ASX, of the Company (as such number may be adjusted as provided herein). The 1,602,319 shares of Common Stock which may be purchased pursuant to this common stock purchase warrant (this “Warrant”) are referred to herein as the “Aggregate Number”. This Warrant is issued under and pursuant to that cer
UNIVERSAL BIOSENSORS, INC. COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • December 20th, 2013 • Universal Biosensors Inc • Surgical & medical instruments & apparatus • New York
THIS IS TO CERTIFY that ATHYRIUM OPPORTUNITIES FUND (A) LP, a Delaware limited partnership, and its permitted transferees, successors and permitted assigns (the “Holder”), for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, is entitled to purchase from UNIVERSAL BIOSENSORS, INC., a Delaware corporation (the “Company”), at the price of AUD$1.00 per share (the “Exercise Price”), at any time after the date hereof (the “Commencement Date”) and expiring on December 19, 2020 (the “Expiration Date”), 2,897,681 shares of the fully paid and non-assessable Common Stock (as defined herein), trading in the form of CHESS depositary interests (“CDIs”) on the ASX, of the Company (as such number may be adjusted as provided herein). The 2,897,681 shares of Common Stock which may be purchased pursuant to this common stock purchase warrant (this “Warrant”) are referred to herein as the “Aggregate Number”. This Warrant is issued under and pursuant to that cer
